Washington RHTP Opioid Treatment Programs Workforce Incentive Program

Washington Rural Health Transformation workforce funding for rural opioid treatment programs, including recruitment and retention incentives tied to sustained rural service.

FundingApproximately $6.2 million per year in Washington RHT program funding; applicant award structure is governed by RFA 2026HCA9 and current amendments.

DeadlineSeptember 8, 2026 at 2:00 PM PT

Last verifiedAugust 28, 2026

Required next actionThe second-round application window closed September 8, 2026 at 2:00 PM Pacific. Retain this record for award tracking, future Washington RHT workforce rounds, and program intelligence. Do not initiate new applicant outreach or treat RFA 2026HCA9 as open.

Broad Eligibility

Qualifying Washington opioid treatment programs serving rural communities under RFA 2026HCA9. Washington program materials identify rural OTP access and workforce stabilization as the target; exact applicant and workforce requirements are controlled by Amendment 3 and the current RFA package.

Atlas Analysis

Opportunity Overview

Washington State Health Care Authority reopened RFA 2026HCA9, the Rural Health Transformation Opioid Treatment Programs Workforce Incentive Program, for a second application round that is now closed. The program supported workforce recruitment and retention for qualifying opioid treatment programs serving rural Washington communities.

Round 2 Deadline

HCA’s current Rural Health Transformation page confirms that the second round of applications closed September 8, 2026 at 2:00 PM Pacific. Organizations that submitted in Round 1 or Round 2 are now in the evaluation period. RFA Amendment 3 remains posted with the official application package on HCA’s bids and contracts page.

Funding and Eligible Use

Washington’s RHT framework allocates approximately $6.2 million per year to rural opioid treatment program recruitment and retention activity. The program is designed around workforce incentives such as recruitment bonuses, relocation support, childcare stipends, capacity payments, and other approved workforce stabilization supports governed by RFA 2026HCA9.

Eligibility

Qualifying Washington opioid treatment programs serving rural communities may apply, subject to the controlling RFA, Amendment 3, applicant forms, budget template, certifications, service-commitment requirements, and all HCA program conditions.

N9+ / QC Strategic Analysis

Atlas Opportunity Score: 88/100. This is an important rural behavioral-health workforce opportunity, but the verified Round 2 scope is workforce recruitment and retention rather than clinical technology acquisition.

N9+ Direct Vendor Fit: low / not material. QC Healthcare Fit: low / not material. Current official materials do not establish a grant-allowable N9+ device, remote-exam platform, or QC clinical-services role. Atlas therefore does not trigger applicant-facing Dr. Miltie vendor outreach solely because Round 2 reopened.

Next Action

The application window is closed. Retain this record for award tracking, future Washington RHT workforce rounds, and program intelligence. Do not initiate new applicant outreach or treat RFA 2026HCA9 as currently open.